loading...| Preferred Name |
brompheniramine |
|
| Synonyms |
Brompheniramine 2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine 3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine [3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine bromfeniramina 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine [3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane brompheniraminum C16H19BrN2 brompheniramine |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_3183 |
|
| altId |
CHEBI:154051 |
|
| ATCCode |
R06AB01 R06AB06 |
|
| blocks |
http://purl.obolibrary.org/obo/dinto_3182 http://purl.obolibrary.org/obo/dinto_1005 http://purl.obolibrary.org/obo/dinto_0703 http://purl.obolibrary.org/obo/dinto_3887 |
|
| CASRN |
86-22-6 |
|
| DBBrand |
bromfenex veltane bromfed dimetane |
|
| DBname |
brompheniramine |
|
| DBSynonym |
brompheniramine maleate |
|
| Definition |
Pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis. |
|
| has effect |
http://purl.obolibrary.org/obo/OAE_0000388 http://purl.obolibrary.org/obo/OAE_0000589 http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0000902 http://purl.obolibrary.org/obo/OAE_0000365 http://purl.obolibrary.org/obo/OAE_0000600 http://purl.obolibrary.org/obo/OAE_0000601 http://purl.obolibrary.org/obo/OAE_0000300 http://purl.obolibrary.org/obo/OAE_0002206 http://purl.obolibrary.org/obo/OAE_0000355 http://purl.obolibrary.org/obo/OAE_0002122 http://purl.obolibrary.org/obo/OAE_0000460 http://purl.obolibrary.org/obo/OAE_0000401 |
|
| has pharmacological target | ||
| has role | ||
| InChI |
InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3 |
|
| InChIKey |
InChIKey=ZDIGNSYAACHWNL-UHFFFAOYSA-N |
|
| inhibits | ||
| is metabolised by |
http://purl.obolibrary.org/obo/dinto_2058 http://purl.obolibrary.org/obo/dinto_2993 http://purl.obolibrary.org/obo/dinto_0293 http://purl.obolibrary.org/obo/dinto_0291 http://purl.obolibrary.org/obo/dinto_0901 |
|
| label |
brompheniramine |
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_42944 http://purl.obolibrary.org/obo/dinto_DB00209 http://purl.obolibrary.org/obo/CHEBI_8874 http://purl.obolibrary.org/obo/CHEBI_53289 http://purl.obolibrary.org/obo/dinto_DB00427 |
|
| prefixIRI |
obo2:CHEBI_3183 |
|
| prefLabel |
brompheniramine |
|
| SMILES |
CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1 CN(C)CCC(c1ccc(Br)cc1)c1ccccn1 |
|
| Synonym |
Brompheniramine 2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine 3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine [3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine bromfeniramina 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine [3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane brompheniraminum C16H19BrN2 brompheniramine |
|
| xref |
NIST Chemistry WebBook:86-22-6 ChEMBL:2570152 Wikipedia:http://en.wikipedia.org/wiki/Brompheniramine Patent:US2567245 ChEMBL:9526560 ChemSpider:6573 PubChem Compound:6834 CASRN:86-22-6 KEGG COMPOUND:C06857 Drugs.com:http://www.drugs.com/cdi/brompheniramine-12-hour-sustained-release-tablets.html DrugBank:DB00835 Drugs Product Database (DPD):2244079 PharmGKB:PA448675 BindingDB:50017666 ChEMBL:2579237 ChEBI:3183 Beilstein:217066 Patent:US2676964 Wikipedia:Brompheniramine KEGG DRUG:D07543 PubChem Substance:46508137 ChEMBL:6458703 |
|
| subClassOf |